George D. Wilbanks

<i>BRCA1</i> and <i>BRCA2</i> mutations account for a large proportion of ovarian carcinoma cases

Tuya Pal, Jenny Permuth‐Wey, Judith A. Betts et al. · Cancer · 2005 · 688 citations

Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer

Robert C. Young, Leslie A. Walton, Susan S. Ellenberg et al. · New England Journal of Medicine · 1990 · 590 citations · Full text

Surgical Oncology, Gynecological Surgery, Health Sciences +15

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Chris J. Scotton, Julia L. Wilson, Kate A Scott et al. · PubMed · 2002 · 479 citations

Reproductive, menstrual, and medical risk factors for endometrial cancer: Results from a case-control study

Louise A. Brinton, Michael L. Berman, Rodrigue Mortel et al. · American Journal of Obstetrics and Gynecology · 1992 · 382 citations

Hormonal Contraceptive, Fertility, Reproductive Health +13

Lysophospholipids Are Potential Biomarkers of Ovarian Cancer

Rebecca Sutphen, Yan Xu, George D. Wilbanks et al. · Cancer Epidemiology Biomarkers & Prevention · 2004 · 336 citations